Results 171 to 180 of about 148,737 (346)

Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study

open access: yesRheumatology International, 2011
E. Tinazzi   +11 more
semanticscholar   +1 more source

Predicting Amyotrophic Lateral Sclerosis Mortality With Machine Learning in Diverse Patient Databases

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction Predicting mortality in Amyotrophic Lateral Sclerosis (ALS) guides personalized care and clinical trial optimization. Existing statistical and machine learning models often rely on baseline or diagnosis visit data, assume fixed predictor‐survival relationships, lack validation in non‐Western populations, and depend on features ...
Ling Guo   +7 more
wiley   +1 more source

A Case of Large Cell Neuroendocrine Carcinoma with Pulmonary Fibrosis Combined with Progressive Systemic Sclerosis.

open access: bronze, 1999
Yoshiharu Ohno   +5 more
openalex   +2 more sources

Spatial transcriptomics identifies SPARC as a prognostic marker in interstitial lung diseases

open access: yesThe Journal of Pathology, EarlyView.
Abstract Interstitial lung diseases (ILDs) encompass a diverse group of pulmonary disorders, with progressive fibrosis leading to poor prognosis. Here we aimed to identify key molecules involved in progressive fibrosis across various ILDs, using spatial transcriptomics (ST).
Takayuki Niitsu   +13 more
wiley   +1 more source

Phytochemical Nanoparticles for the Treatment of Neurological Disorders

open access: yesPhytochemical Analysis, EarlyView.
ABSTRACT Neurological disorders impose a significant burden on the healthcare systems. The latest published data by WHO indicated that stroke was the second leading cause of death globally in 2020, with Alzheimer's disease (AD) and other dementias in the seventh position.
Touraj Ehtezazi, Satyajit D. Sarker
wiley   +1 more source

High-dose chemotherapy and autologous hematopoietic stem cell transplantation for progressive systemic sclerosis: a retrospective study of outcome and prognostic factors. [PDF]

open access: yesJ Cancer Res Clin Oncol
Pyka V   +8 more
europepmc   +1 more source

Multi‐omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosis

open access: hybridThe FEBS Journal, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease, and lung complications (ILD) are the main cause of death. This study compared SSc patients with and without lung disease to healthy volunteers. We found increased inflammation, specific proteins, and higher triglyceride levels linked to lung disease progression. These findings suggest triglycerides
Selena Bouffette   +16 more
openalex   +2 more sources

Proteomic Insight Into Alzheimer's Disease Pathogenesis Pathways

open access: yesPROTEOMICS, EarlyView.
ABSTRACT Alzheimer's disease (AD) is a leading cause of dementia, but the pathogenesis mechanism is still elusive. Advances in proteomics have uncovered key molecular mechanisms underlying AD, revealing a complex network of dysregulated pathways, including amyloid metabolism, tau pathology, apolipoprotein E (APOE), protein degradation ...
Taekyung Ryu   +3 more
wiley   +1 more source

Clinical periodontal diagnosis

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi   +5 more
wiley   +1 more source

Exploratory clinical subgroup clustering in systemic sclerosis: Results from the Indian Progressive Systemic Sclerosis Registry. [PDF]

open access: yesJ Scleroderma Relat Disord
Philip SS   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy